Correction to: Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies. [PDF]
Senna M +12 more
europepmc +1 more source
Alopecia totalis sparing congenital melanocytic nevus: Renbök phenomenon
Toshiyuki Yamamoto +2 more
doaj +1 more source
Feasibility of stepwise baricitinib tapering after complete response in alopecia areata: A real-world observational cohort study. [PDF]
Seo HR, Kim DY.
europepmc +1 more source
Dental Rehabilitation of a Child Diagnosed With Alopecia Areata Totalis: A Case Report. [PDF]
Abou Samra N, Aboujaoude S.
europepmc +1 more source
Treatment of concomitant alopecia areata and systemic lupus erythematosus with ivarmacitinib: a case report and literature review. [PDF]
Li W +5 more
europepmc +1 more source
Coexistence of cicatricial alopecia and alopecia areata: A case series. [PDF]
Paz M +7 more
europepmc +1 more source
The dose matters: Oral tofacitinib dose escalation or switching to deuruxolitinib for recalcitrant alopecia universalis and totalis, a retrospective case series. [PDF]
Ezzat RZ, Paz M, Kreytak C, Senna MM.
europepmc +1 more source
A Comprehensive Overview on Alopecia Areata with Review on Advances in Genetics and Treatment. [PDF]
Das S, Singh A, Ahmed SS.
europepmc +1 more source
Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study. [PDF]
Ke X, Gao Y, Huang J, Li J, Wu A, Shi W.
europepmc +1 more source
Excimer light 308 nm therapy for alopecia areata resistant to other treatments: a clinical study of three patients. [PDF]
Hermosilla DM +3 more
europepmc +1 more source

